Bulletin
Investor Alert

PTC Therapeutics Inc.

NAS: PTCT

GO
/marketstate/country/us

After Hours

/zigman2/quotes/205664747/composite

$

46.60

Change

0.00 0.00%

Volume

Volume 105,117

Sep 25, 2020, 4:29 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205664747/composite

Today's close

$ 46.38

$ 46.60

Change

+0.22 +0.47%

Day low

Day high

$45.95

$47.80

Open
Open: 46.48

52 week low

52 week high

$30.79

$59.89

Open

Market cap

$3.14B

Average volume

765,105

P/E ratio

N/A

Rev. per Employee

$512,058

EPS

-7.03

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/ptct

MarketWatch News on PTCT

  1. PTC Therapeutics started at outperform with $63 price target at Raymond James

    8:22 a.m. Aug. 25, 2020

    - Tonya Garcia

  2. FDA approves Roche's new spinal muscular atrophy drug

    10:40 a.m. Aug. 8, 2020

    - Jaimy Lee

  3. Our Roundtable Experts Pick 14 Biotech Stocks

    6:10 p.m. Oct. 2, 2019

    - Barron's Online

  4. 2 Small Biotech Stocks Make Citi’s Top 5 List

    3:39 p.m. Sept. 17, 2019

    - Barron's Online

  5. How Biotech Is Targeting RNA to Cure Diseases

    8:01 a.m. Sept. 3, 2019

    - Barron's Online

  6. How to Make a Killing in Gene Therapy

    12:56 p.m. Sept. 18, 2018

    - Barron's Online

  7. PTC Therapeutics stock halted for pending news

    4:01 p.m. July 19, 2018

    - MarketWatch

  8. Charting the Market

    9:56 p.m. June 22, 2018

    - Barron's Online

  9. Microsoft, Six Flags, and Other Income Plays

    5:12 p.m. June 20, 2018

    - Barron's Online

  10. Big Biotech Buys: Vericel, Achillion, PTC, Dicerna

    1:33 p.m. March 1, 2018

    - Barron's Online

  11. PTC Therapeutics stock price target raised to $30 from $15 at RBC Capital

    8:25 a.m. Jan. 29, 2018

    - Tomi Kilgore

  12. PTC Therapeutics upgraded to neutral from underweight at J.P. Morgan

    8:55 a.m. Nov. 16, 2017

    - Tomi Kilgore

  13. PTC Therapeutics stock price target cut to $15 from $23 at J.P. Morgan

    7:57 a.m. Oct. 9, 2017

    - Tomi Kilgore

  14. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/ptct

Other News on PTCT

  1. PTC Therapeutics (PTCT) Gets a Buy Rating from Raymond James

    4:36 p.m. Sept. 23, 2020

    - SmarterAnalyst

  2. Royalty Pharma Is the Left-Field Investment You’re Missing Out On

    2:49 p.m. Aug. 27, 2020

    - InvestorPlace.com

  3. Dyne Therapeutics on deck for IPO

    6:36 a.m. Aug. 26, 2020

    - Seeking Alpha

  4. PTC Therapeutics' Application for SMA Drug Accepted by EU

    5:07 p.m. Aug. 18, 2020

    - Zacks.com

  5. PTC Therapeutics (PTCT) Gets a Hold Rating from Cowen & Co.

    5:05 a.m. Aug. 10, 2020

    - SmarterAnalyst

  6. PTC Therapeutics (PTCT) Gets a Buy Rating from William Blair

    7:55 p.m. Aug. 5, 2020

    - SmarterAnalyst

  7. 10-Q: PTC THERAPEUTICS, INC.

    4:49 p.m. Aug. 5, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  8. PTC Therapeutics Q2 2020 Earnings Preview

    5:35 p.m. Aug. 4, 2020

    - Seeking Alpha

  9. Loading more headlines...
/news/pressrelease/company/us/ptct

Press Releases on PTCT

  1. PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    4:30 p.m. Today

    - PR Newswire - PRF

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.